Are We on the Right Track?: Overview of Unregistered Drugs in Malaysia

  title={Are We on the Right Track?: Overview of Unregistered Drugs in Malaysia},
  author={Nur Wahida Zulkifli and Noorizan Abd. Aziz and Yahaya Bin Hassan and Mohamed Azmi Hassali and Nur Liyana Zainal Bahrin and Azlan bin Ahmad},
Background: The Ministry of Health (MOH) under their sub-division, the Pharmacy Enforcement Division (PED) has a crucial role in managing unregistered drugs in Malaysia market. The unregistered drug is like a silence killer in the pharmaceutical industry. It does damage not only the pharmaceutical economy but also the consumers’ health. PED aims are to ensure that every pharmaceutical, traditional and cosmetic are quality, safe and efficient to be used meaning they need to be registered and… 

Figures from this paper

Unregistered Medical Products Detected by Malaysia’s Pharmacy Enforcement Division During Routine Inspection: A Cross-Sectional Study among Selected Mainstream Medicines’ Retailers in the State of Sarawak
The findings of this study provide preliminary information to relevant authorities on the UMPs detected by PED officers during routine inspections among selected MMRs in Sarawak throughout the year 2016.
In vitro quality assessment of ten brands of metronidazole benzoate suspensions marketed in Warri, Nigeria
Nine of the brands met with their label claims of metronidazole benzoate content based on British Pharmacopoeia specification and can be considered fit for distribution and consumption, except one brand (MET-A), that failed.


Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic.
Lethal Counterfeits
  • P. Park
  • Medicine
    World policy journal
  • 2010
The border between Thailand and Cambodia is a petri dish for drug-resistant strains of malaria, and scientists have not yet seen evidence that full-fledged resistance has developed along the Thai-Cambodian border, but the parasite does seem to be developing a tolerance to the drugs.
Counterfeiting of drugs in Brazil.
Identification of the classes of counterfeit drugs present in Brazil and the main Brazilian states with this problem may facilitate future preventive and suppressive actions by the Brazilian bodies responsible for such actions.
Enforcement efforts and partnership with industry: A needed strategy addressing counterfeit drugs
Despite some law enforcement successes, organizations engaged in counterfeiting continued manufacturing, distributing and selling a wide range of unsafe medicines during the past year. This article
Beef up international cooperation on counterfeits
The number of counterfeit medicines on the market has increased as much as 25% each year over the past several years, according to industry insiders.
An overview
The objective of this introductory note, is to highlight some of the areas that would need much great attention from scientists working in various disciplines in this country to answer several questions on infectious diseases, that are prevalent in the authors' environment, to focus on the information conveyed in the following articles.
Understanding counterfeit consumption
Purpose – The purpose of this paper is to create a framework for broadly understanding categories and motivations behind purchasing different counterfeit products. Design/methodology/approach – Focus
Counterfeiting in China
II. The Western Conception of Intellectual Property 18 A. Copyrights 19 B. Patents 19 C. Trademarks 20 D. Trade Secrets 20
This presentation will highlight the mental health consequences of trauma with special attention to COVID-19 and the trauma of oppression. Ways of countering burnout and vicarious trauma for